Expression of MAP kinase kinase-5 (MEK5) in human prostate cancer

被引：0
|
作者：
Jenkins, BL [1 ]
Mehta, PB [1 ]
Robson, CN [1 ]
Neal, DE [1 ]
Leung, HY [1 ]
机构：
[1] Univ Newcastle Upon Tyne, Sch Med, Dept Surg & Reprod Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
来源：
BRITISH JOURNAL OF CANCER | 2001年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [31] The activation and inhibition of cyclin-dependent kinase-5 by phosphorylation
    Zhang, B.
    Tan, V. B. C.
    Lim, K. M.
    Tay, T. E.
    BIOCHEMISTRY, 2007, 46 (38) : 10841 - 10851
  • [32] Regulation of NMDA receptors by cyclin-dependent kinase-5
    Li, BS
    Sun, MK
    Zhang, L
    Takahashi, S
    Ma, W
    Vinade, L
    Kulkarni, AB
    Brady, RO
    Pant, HC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (22) : 12742 - 12747
  • [33] Targeted Avenues for Cancer Treatment: The MEK5?ERK5 Signaling Pathway
    Pereira, Diane M.
    Rodrigues, Cecilia M. P.
    TRENDS IN MOLECULAR MEDICINE, 2020, 26 (04) : 394 - 407
  • [34] Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition
    Jeffrey F Ohren
    Huifen Chen
    Alexander Pavlovsky
    Christopher Whitehead
    Erli Zhang
    Peter Kuffa
    Chunhong Yan
    Patrick McConnell
    Cindy Spessard
    Craig Banotai
    W Thomas Mueller
    Amy Delaney
    Charles Omer
    Judith Sebolt-Leopold
    David T Dudley
    Iris K Leung
    Cathlin Flamme
    Joseph Warmus
    Michael Kaufman
    Stephen Barrett
    Haile Tecle
    Charles A Hasemann
    Nature Structural & Molecular Biology, 2004, 11 : 1192 - 1197
  • [35] Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition
    Ohren, JF
    Chen, HF
    Pavlovsky, A
    Whitehead, C
    Zhang, EL
    Kuffa, P
    Yan, CH
    McConnell, P
    Spessard, C
    Banotai, C
    Mueller, WT
    Delaney, A
    Omer, C
    Sebolt-Leopold, J
    Dudley, DT
    Leung, IK
    Flamme, C
    Warmus, J
    Kaufman, M
    Barrett, S
    Tecle, H
    Hasemann, CA
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (12) : 1192 - 1197
  • [36] The MEK5/ERK5 Pathway in Health and Disease
    Paudel, Rupesh
    Fusi, Lorenza
    Schmidt, Marc
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)
  • [37] Cyclin-dependent kinase-5 targeting for ischaemic stroke
    Slevin, Mark
    Krupinski, Jerzy
    CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (02) : 119 - 124
  • [38] LOCALIZATION OF THE MITOGEN-ACTIVATED PROTEIN-KINASE ERK5 AND ITS UPSTREAM ACTIVATOR MEK5 IN RAT-BRAIN
    CHAO, HHJ
    KWAK, SP
    DIXON, JE
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 736 - 736
  • [39] Exploration of quinazoline derivates as MEK5 inhibitors
    Flaherty, Patrick
    Wright, Thomas
    Motta, Austin
    Cavanaugh, Jane
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [40] Selective allosteric inhibition of MEK5: novel target for cancer therapeutics
    Gupta, Mohit
    Shah, Dhruv
    Flaherty, Patrick
    Wright, Thomas
    Bhatt, Akshita
    Cavanaugh, Jane
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
12345